Crossmark

Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment

Crossref DOI link: https://doi.org/10.1007/s00430-018-0538-1

Published Online: 2018-03-09

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Parisi, Saverio G.

Andreis, Samantha

Mengoli, Carlo

Menegotto, Nicola

Cavinato, Silvia

Scaggiante, Renzo

Andreoni, Massimo

Palù, Giorgio

Basso, Monica

Cattelan, Anna Maria
Funding

Funding for this research was provided by:

unconditioned grant from Gilead Sciences srl
License Information

Text and Data Mining valid from 2018-03-09
More Information

Article History

Received: 4 December 2017

Accepted: 5 March 2018

First Online: 9 March 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study was conducted in accordance with the Declaration of Helsinki and local legislation and was approved by the local Ethics Committee (2606-12P).

: The enrolled subjects provided informed consent for all procedures and the use of their blinded data for scientific evaluation and publication.

Document is current

Any future updates will be listed below